This gradual increase in dosage ensures a more comfortable experience for most patients
[8] Kalra S, et al
Thats why telehealth startups which present themselves as care delivery or wellness enablement platforms often fall outside those boundaries, even when they prescribe or distribute regulated drugs
Orals are also being launched I think it was over estimated for the short term and now being underestimated for the long term Mounjaro has become 0.8-0.9 % of the indian market no other drug is even half of it and that it in about 18 months
There is one important protection worth noting: "If you are not a candidate or approved for GLP-1 medication, your subscription will be cancelled, and we will work with you to find another solution." The company also states elsewhere that "if not deemed appropriate, you will be immediately refunded." The practical takeaway: the billing structure is quarterly, cancellation is available but fees already paid are described as non-refundable, and there is a minimum commitment period described in the terms
Your clinician helps determine what is appropriate based on your health history, goals, and eligibility